Hemodynamic investigation of peritumoral impaired blood oxygenation-level dependent cerebrovascular reactivity in patients with diffuse glioma.

[1]  A. Luft,et al.  Characterizing ipsilateral thalamic diaschisis in symptomatic cerebrovascular steno-occlusive patients , 2020, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[2]  A. Luft,et al.  BOLD cerebrovascular reactivity as a novel marker for crossed cerebellar diaschisis , 2018, Neurology.

[3]  P. Delgado-López,et al.  Treatment-related changes in glioblastoma: a review on the controversies in response assessment criteria and the concepts of true progression, pseudoprogression, pseudoresponse and radionecrosis , 2018, Clinical and Translational Oncology.

[4]  Marco Piccirelli,et al.  Impact of baseline CO2 on Blood-Oxygenation-Level-Dependent MRI measurements of cerebrovascular reactivity and task-evoked signal activation. , 2018, Magnetic resonance imaging.

[5]  Alejandro F. Frangi,et al.  Characterization of active and infiltrative tumorous subregions from normal tissue in brain gliomas using multiparametric MRI , 2018, Journal of magnetic resonance imaging : JMRI.

[6]  Paolo Vitali,et al.  Brain Gliomas: Multicenter Standardized Assessment of Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast MR Images. , 2018, Radiology.

[7]  Seong-Whan Lee,et al.  Tumor Tissue Detection using Blood-Oxygen-Level-Dependent Functional MRI based on Independent Component Analysis , 2018, Scientific Reports.

[8]  S. Li,et al.  Anatomic Location of Tumor Predicts the Accuracy of Motor Function Localization in Diffuse Lower-Grade Gliomas Involving the Hand Knob Area , 2017, American Journal of Neuroradiology.

[9]  F. Tensaouti,et al.  Response Assessment in Neuro-Oncology criteria, contrast enhancement and perfusion MRI for assessing progression in glioblastoma , 2017, Neuroradiology.

[10]  A. Luft,et al.  Iterative analysis of cerebrovascular reactivity dynamic response by temporal decomposition , 2017, Brain and behavior.

[11]  A. F. Delgado,et al.  Discrimination between Glioma Grades II and III Using Dynamic Susceptibility Perfusion MRI: A Meta-Analysis , 2017, American Journal of Neuroradiology.

[12]  Rebecca W. Pak,et al.  Implications of neurovascular uncoupling in functional magnetic resonance imaging (fMRI) of brain tumors , 2017, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[13]  Sumei Wang,et al.  Clinical Applications of Contrast-Enhanced Perfusion MRI Techniques in Gliomas: Recent Advances and Current Challenges , 2017, Contrast media & molecular imaging.

[14]  C. Thompson,et al.  Metabolic Reprogramming in Brain Tumors. , 2017, Annual review of pathology.

[15]  Ho Sung Kim,et al.  Emerging Techniques in Brain Tumor Imaging: What Radiologists Need to Know , 2016, Korean journal of radiology.

[16]  Kyung K Peck,et al.  Brain Tumors: The Influence of Tumor Type and Routine MR Imaging Characteristics at BOLD Functional MR Imaging in the Primary Motor Gyrus. , 2016, Radiology.

[17]  Marco Piccirelli,et al.  Altered intraoperative cerebrovascular reactivity in brain areas of high-grade glioma recurrence. , 2016, Magnetic resonance imaging.

[18]  Kyung K Peck,et al.  Vascular Reactivity Maps in Patients with Gliomas Using Breath‐Holding BOLD fMRI , 2016, Journal of neuroimaging : official journal of the American Society of Neuroimaging.

[19]  Shruti Agarwal,et al.  Neurovascular uncoupling in resting state fMRI demonstrated in patients with primary brain gliomas , 2016, Journal of magnetic resonance imaging : JMRI.

[20]  Jennie W. Taylor,et al.  Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  J. Provenzale,et al.  Magnetic resonance perfusion for differentiating low-grade from high-grade gliomas at first presentation. , 2015, The Cochrane database of systematic reviews.

[22]  D J Mikulis,et al.  Cerebrovascular Reactivity Mapping: An Evolving Standard for Clinical Functional Imaging , 2015, American Journal of Neuroradiology.

[23]  Joseph A. Fisher,et al.  A conceptual model for CO2-induced redistribution of cerebral blood flow with experimental confirmation using BOLD MRI , 2014, NeuroImage.

[24]  D J Mikulis,et al.  Measuring cerebrovascular reactivity: what stimulus to use? , 2013, The Journal of physiology.

[25]  Howard Colman,et al.  IDH1 and IDH2 Mutations in Gliomas , 2013, Current Neurology and Neuroscience Reports.

[26]  Jay J Pillai,et al.  Comparison of BOLD Cerebrovascular Reactivity Mapping and DSC MR Perfusion Imaging for Prediction of Neurovascular Uncoupling Potential in Brain Tumors , 2012, Technology in cancer research & treatment.

[27]  Jay J Pillai,et al.  Clinical utility of cerebrovascular reactivity mapping in patients with low grade gliomas. , 2011, World journal of clinical oncology.

[28]  Heinrich Lanfermann,et al.  Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas , 2010, The Lancet Neurology.

[29]  A. Kassner,et al.  Texture Analysis: A Review of Neurologic MR Imaging Applications , 2010, American Journal of Neuroradiology.

[30]  E. Cho,et al.  The Blood Oxygen Level–Dependent Functional MR Imaging Signal Can Be Used to Identify Brain Tumors and Distinguish Them from Normal Tissue , 2008, American Journal of Neuroradiology.

[31]  Y. Benjamini,et al.  Adaptive linear step-up procedures that control the false discovery rate , 2006 .

[32]  J. K. Smith,et al.  Vessel tortuosity and brain tumor malignancy: a blinded study. , 2005, Academic radiology.

[33]  R. Jain Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy , 2005, Science.

[34]  J A Maldjian,et al.  The effect of brain tumors on BOLD functional MR imaging activation in the adjacent motor cortex: implications for image-guided neurosurgery. , 2000, AJNR. American journal of neuroradiology.

[35]  T. L. Davis,et al.  Calibrated functional MRI: mapping the dynamics of oxidative metabolism. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Weller,et al.  Diffuse gliomas exhibit whole brain impaired cerebrovascular reactivity. , 2018, Magnetic resonance imaging.

[37]  Diana Delgado,et al.  MR perfusion-weighted imaging in the evaluation of high-grade gliomas after treatment: a systematic review and meta-analysis , 2017, Neuro-oncology.

[38]  Jitender Saini,et al.  Differentiation of grade II/III and grade IV glioma by combining “T1 contrast-enhanced brain perfusion imaging” and susceptibility-weighted quantitative imaging , 2017, Neuroradiology.

[39]  Timo Krings,et al.  Impaired peri-nidal cerebrovascular reserve in seizure patients with brain arteriovenous malformations. , 2011, Brain : a journal of neurology.

[40]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .